Skip to main content
. 2015 Jan 21;12:5. doi: 10.1186/s12970-014-0066-3

Table 3.

DALDA (Daily Analysis of Life Demands on Athletes) questionnaire responses (median & range) for both training and trial days

DALDA part 1 (training day) stress sources DALDA (part 2 training day) stress symptoms
RESPONSE A (Worse) B (Same) C (Better) A (Worse) B (Same) C (Better)
CURCUMIN (n = 11) 0 (0–3) 4 (4–9) 3 (0–5) 1 (0–4) 21(4–25) 3 (0–19)†
PLACEBO (n = 11) 1 (0–5) 7 (2–9) 1 (0–6) 2 (0–7) 20 (8–25) 2 (0–15)
CONTROL (n = 10) 2 (0–3) 6 (2–9) 0 (0–7) 2 (0–9) 22 (5–25) 2 (0–18)
DALDA part 1 (trial day) stress sources DALDA part 2 (trial day) stress symptoms
RESPONSE A (Worse) B (Same) C (Better) A (Worse) B (Same) C (Better)
CURCUMIN (n = 11) 2 (0–4) 6 (2–9) 1 (0–7) 2 (0–5) 22 (5–25) 1 (0–20)
PLACEBO (n = 11) 1 (0–5) 8 (2–9) 0 (0–6) 1 (0–6) 23 (5–25) 0 (0–18)
CONTROL (n = 10) 2 (0–3) 7 (3–9) 0 (0–6) 3 (0–8) 22 (4–25) 1 (0–19)

Data is grouped according to trial type. A – Worse than usual; B – Same as usual; C – Better than usual. indicates statistical significant difference between curcumin and placebo trials, p-value in both parts between curcumin and placebo is 0.04 using Wilcoxon signed ranks.